Qinghai Comprehensively Regulates Dental Diagnosis and Treatment, Tightens Access Management; Jilin Health Commission Abolishes the “Age Equals Scrap” Convention for Medical Equipment; Hunan Standard…

Hunan Standardizes Pricing for Surgical Assistance Procedures: Maximum Price for "Oral Medical 3D Guide Printing" Set at 1,500 RMB per Unit

On May 14, 2026, the Hunan Provincial Medical Security Bureau issued a "Notice" setting the maximum price for the "Oral Medical 3D Guide Printing" category at 1,500 RMB per unit. For services such as medical 3D reconstruction and surgical navigation, if data storage and upload services are not provided, a deduction of 100 RMB per item applies. Surgical robotic arms will incur additional charges of up to 3,600 RMB, 12,000 RMB, and 26,000 RMB based on the degree of involvement, while remote surgery will incur an additional charge of up to 37,000 RMB. The policy takes effect on September 1, 2026, with a validity period of five years.

Qinghai Comprehensively Regulates Dental Diagnosis and Treatment: Tightened Access Management, City-Level Quality Control Centers to Be Established by End of June

On May 19, the Qinghai Provincial Health Commission issued a "Notice on Further Regulating Dental Diagnosis and Treatment Service Management," requiring all cities (prefectures) in the province to establish dental quality control centers by the end of June 2026. It also mandates the implementation of six major regulatory measures, including the "one person, one use, one disinfection/sterilization" rule, covering access management, quality and safety, pricing and charges, advertising, self-inspection and rectification, and coordinated supervision. The notice also requires institutions to clearly display prices, prohibit false advertising, and conduct at least one self-inspection annually.

Jilin Health Commission: Abolishes the "Expiration Equals Scrapping" Convention for Medical Equipment, Technical Assessment Becomes Primary Evaluation Basis

On April 16, 2026, the Jilin Provincial Health Commission publicly responded on the provincial government website, officially halting the mandatory scrapping of medical equipment upon expiration. It clarified that technical assessment should be the primary basis, with equipment lifespan serving only as a reference. The commission requires the formation of joint evaluation teams comprising equipment management, clinical, and quality control personnel. When necessary, third parties may be commissioned to conduct comprehensive assessments of equipment safety, performance accuracy, and maintenance cost-effectiveness.

"White Paper on Microscopic Technology Applications in Private Dentistry" Released: Under the Separation of Technology and Consumables, Technical Premium Ushers in New Opportunities

On May 21, at the 18th Private Dental Annual Conference, Zumax Medical and DENTALGOODNEWS (Leading Dental Industry Media, DGN) jointly released the "White Paper on Microscopic Technology Applications in Private Dentistry." Based on 561 valid questionnaires and in-depth interviews with 10 institutions, the white paper systematically presents the pathway choices and key decision-making logic for the current penetration stage of microscopic technology implementation. Data shows that the penetration rate of microscopic equipment in China is approximately 7%. Among the surveyed institutions, 90.2% recognize the technical value, but 53.8% believe that the lengthy learning curve is a major barrier. Chen Xuefeng, Chairman of the Private Dental Medical Branch of the Chinese Stomatological Association, stated: "This white paper directly addresses industry pain points such as 'purchasing but struggling to master' in clinical practice and 'disconnection between learning and application' in talent development, systematically outlining a feasible path from technology implementation to performance conversion."

New Regulations on Complaints and Reports by the State Administration for Market Regulation Take Effect: Criteria for Malicious Claims Clarified to Curb "Professional Extortion"

On April 15, 2026, the State Administration for Market Regulation issued Regulation No. 121, the "Measures for Handling Complaints and Reports in Market Regulation," which took effect immediately upon issuance, replacing the previous "Interim Measures." For the first time, the new regulation explicitly lists criteria for determining "non-consumer living purposes" in article form, requiring complainants to provide true identity information, or the complaint will not be accepted. For malicious claims involving extortion, the regulation stipulates termination of mediation and referral to public security. It also introduces the "non bis in idem" principle to improve administrative efficiency. The regulation has been piloted in Hefei, Fujian, and other locations, aiming to protect market entities from harassment by "professional counterfeit hunters."

Dentium 2026 Q1: Consolidated Revenue of 321 Million RMB, China Market Revenue Share Rises to 45%

On May 15, 2026, Dentium released its Q1 2026 report, with consolidated revenue of approximately 71.383 billion KRW (about 321 million RMB). Among this, China market revenue was 32.119 billion KRW (about 145 million RMB), accounting for 45% of the total. The company canceled 2,444,939 common shares through profit transfer and cancellation this quarter, reducing outstanding common shares to 8,623,891, a decrease of approximately 21.8%. R&D expenses were approximately 1.879 billion KRW (about 84.555 million RMB), accounting for 3.7% of revenue. The capital buyback plan has an upper limit of 60 billion KRW, with a first-month progress rate of 9.2%.

MegaGen Implant 2026 Q1: Revenue of 349 Million RMB, Overseas Sales Account for 68% of Total Revenue

On May 15, 2026, South Korean dental implant company MegaGen Implant released its Q1 2026 report, with operating revenue of approximately 349 million RMB, a year-on-year increase of 10%. Overseas sales accounted for 68% of total revenue, and R&D investment was 3.425 billion KRW, accounting for 4.41%. The company noted that its MINEC education system has established educational branches in over 30 countries globally and has maintained the top position in European exports among South Korean implant companies for 13 consecutive years.

*ST HILE: HILE Dental Established, Equity Transfer of Seven Dental Chains in Yangzhou and Changzhou Completed

On May 21, 2026, Jiangsu HILE Dental Medical Management Co., Ltd., a second-tier subsidiary of Shanghai HILE Bio-Technology Co., Ltd., completed its industrial and commercial registration with a registered capital of 15 million RMB. It has acquired 100% equity of seven dental chain companies in Yangzhou and Changzhou. It is expected to add approximately 100 million RMB in operating revenue and 7 million RMB in net profit in 2026. The company reminds that risks remain in the transfer and subsequent integration and will continue to fulfill disclosure obligations.

Shining 3D: Shanghai Securities Withdraws from Market-Making Business, BSE IPO Review Remains Suspended

On May 20, 2026, Shanghai Securities withdrew from providing market-making quotation services for Shining 3D (Code: 830978). This withdrawal has been approved by the National Equities Exchange and Quotations Co., Ltd. Shining 3D's annual report shows that the company's 2025 revenue was 1.575 billion RMB, a year-on-year increase of 31.03%, with net profit attributable to shareholders of the parent company at 425 million RMB. As of press time, Shining 3D has not issued further explanations regarding this market-maker adjustment.

Fined 2 Million RMB and Business License Revoked: Changsha Leshasha Dental Penalized for Concealing Debt and Falsifying Equity Transfer

On April 22, 2026, Changsha Leshasha Dental Clinic Co., Ltd. was fined 2 million RMB and had its business license revoked by the Furong District Administrative Law Enforcement Bureau for submitting false materials and concealing patient debts exceeding 2.55 million RMB. Investigation showed that from May 2024 to July 2025, the institution received approximately 9.96 million RMB in patient treatment fees, but only recorded about 450,000 RMB on its books, a discrepancy of approximately 4.09 million RMB, with the destination of the funds unknown. The company subsequently closed its doors and ceased operations, leaving hundreds of patients unable to recover their prepayments. As of press time, the institution has not publicly responded to the penalty.

Biopharmaceutical Company ProEncia Completes Pre-Seed Financing, Non-Invasive Full-Periodontal Disease Solution Enters PCT Patent Application Stage

On May 19, 2026, ProEncia Biotechnology, a biopharmaceutical startup based in Minnesota, USA, completed a pre-seed financing round. The amount was not disclosed, with funds allocated for the research, development, commercialization, and licensing of non-invasive full-periodontal care products. On the same day, the company converted its provisional patent (No. 63/765,225) into a non-provisional PCT international application (No. 19/548,447) to advance its patent strategy. The company states that its products cover all stages from gingivitis to periodontitis and have completed early-stage clinical case studies. As of press time, the financing amount, investors, and the official clinical trial timeline for the product have not been disclosed.

New Data: 72% of US Regions Face Dentist Shortages, 60% of Clinics Report Urgent Hiring Needs

In 2025, Clarify Capital released a report titled "Best Cities for Dentists in the US," ranking Scottsdale, Arizona, as the top city for dentists to live and practice based on comprehensive indicators such as employment and patient demand. The report shows that 60% of dental clinics nationwide are currently hiring, 84% find it difficult to fill vacancies, 72% of regions face dentist shortages, and 57% report patient appointment delays due to these shortages. Among respondents, 47% would use loans to purchase new equipment, 45% to increase salaries, 43% to expand hiring, and 29% are considering expansion or renovation.

One-Quarter of US Oral and Maxillofacial Surgeons May Cease Practice Within Eight Years

On May 20, 2026, the "Journal of the American College of Surgeons" published a national longitudinal cohort study showing an 8-year cumulative attrition rate of 9.7% among US surgeons, with oral and maxillofacial surgeons having the highest 5-year cumulative attrition rate at 25.1%. The study indicates that surgeons with 10 to 14 years of practice face the highest risk of attrition, with a hazard ratio of 2.58, and that gender has no significant impact on attrition. The industry has sought talent retention solutions through financing, with Allied OMS, an oral and maxillofacial surgery management services organization, recently securing 245 million USD in funding.

First US 3D Printing Center Integrating R&D, Education, and Clinical Practice Launched, Claiming to Manufacture Single-Unit Complete Dentures in Hours

On May 18, 2026, the University of Colorado Anschutz School of Dental Medicine launched a 3D printing center, utilizing multi-material inkjet technology to produce single-unit complete dentures in hours. The technology, developed by the Jeffrey Stansbury laboratory, was brought to market in 2025 by Myerson and Henry Schein and has received FDA clearance. The center will conduct blinded clinical trials comparing traditional compression-molded dentures with printed dentures. The project is also developing antimicrobial polymers and incorporating digital dentistry into the curriculum. The University of Colorado system has over 68,000 students and 7,600 full-time faculty and staff.